Oscar L Lopez

Author PubWeight™ 203.23‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke 2011 10.11
2 Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet 2011 10.07
3 Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA 2010 9.52
4 Ginkgo biloba for prevention of dementia: a randomized controlled trial. JAMA 2008 6.00
5 Genomewide association studies of stroke. N Engl J Med 2009 5.29
6 Developing a national strategy to prevent dementia: Leon Thal Symposium 2009. Alzheimers Dement 2010 4.85
7 Depressive symptoms, vascular disease, and mild cognitive impairment: findings from the Cardiovascular Health Study. Arch Gen Psychiatry 2006 3.61
8 Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases. Acta Neuropathol 2007 3.55
9 Incidence and prevalence of dementia in the Cardiovascular Health Study. J Am Geriatr Soc 2004 3.43
10 Physical activity, APOE genotype, and dementia risk: findings from the Cardiovascular Health Cognition Study. Am J Epidemiol 2005 3.10
11 The long-term effects of conventional and atypical antipsychotics in patients with probable Alzheimer's disease. Am J Psychiatry 2013 3.06
12 Brain structure and obesity. Hum Brain Mapp 2010 3.04
13 Risk factors for dementia in the cardiovascular health cognition study. Neuroepidemiology 2003 2.97
14 Thinning of the cerebral cortex visualized in HIV/AIDS reflects CD4+ T lymphocyte decline. Proc Natl Acad Sci U S A 2005 2.79
15 Midlife and late-life obesity and the risk of dementia: cardiovascular health study. Arch Neurol 2009 2.79
16 Mild cognitive impairment and alzheimer disease: patterns of altered cerebral blood flow at MR imaging. Radiology 2009 2.70
17 3D pattern of brain atrophy in HIV/AIDS visualized using tensor-based morphometry. Neuroimage 2006 2.69
18 Dementia with Lewy bodies. Lancet Neurol 2004 2.66
19 Amyloid imaging in mild cognitive impairment subtypes. Ann Neurol 2009 2.66
20 Ginkgo biloba for preventing cognitive decline in older adults: a randomized trial. JAMA 2009 2.59
21 Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E ϵ4,and the risk of late-onset Alzheimer disease in African Americans. JAMA 2013 2.58
22 Genome-wide association studies of cerebral white matter lesion burden: the CHARGE consortium. Ann Neurol 2011 2.37
23 Perspectives on depression, mild cognitive impairment, and cognitive decline. Arch Gen Psychiatry 2006 2.29
24 GBA mutations increase risk for Lewy body disease with and without Alzheimer disease pathology. Neurology 2012 2.19
25 A commonly carried allele of the obesity-related FTO gene is associated with reduced brain volume in the healthy elderly. Proc Natl Acad Sci U S A 2010 2.12
26 Novel late-onset Alzheimer disease loci variants associate with brain gene expression. Neurology 2012 2.08
27 3D mapping of ventricular and corpus callosum abnormalities in HIV/AIDS. Neuroimage 2006 1.93
28 Differential cortical atrophy in subgroups of mild cognitive impairment. Arch Neurol 2005 1.92
29 The Ginkgo Evaluation of Memory (GEM) study: design and baseline data of a randomized trial of Ginkgo biloba extract in prevention of dementia. Contemp Clin Trials 2006 1.88
30 Prevalence of cognitive disorders differs as a function of age in HIV virus infection. AIDS 2004 1.84
31 Common variants at 12q14 and 12q24 are associated with hippocampal volume. Nat Genet 2012 1.79
32 Tracking Alzheimer's disease. Ann N Y Acad Sci 2007 1.78
33 Statin use and the risk of incident dementia: the Cardiovascular Health Study. Arch Neurol 2005 1.76
34 Enhanced risk for Alzheimer disease in persons with type 2 diabetes and APOE epsilon4: the Cardiovascular Health Study Cognition Study. Arch Neurol 2008 1.74
35 Obesity is linked with lower brain volume in 700 AD and MCI patients. Neurobiol Aging 2010 1.69
36 Three-dimensional patterns of hippocampal atrophy in mild cognitive impairment. Arch Neurol 2006 1.65
37 Can performance on daily activities discriminate between older adults with normal cognitive function and those with mild cognitive impairment? J Am Geriatr Soc 2014 1.65
38 Survival following dementia onset: Alzheimer's disease and vascular dementia. J Neurol Sci 2004 1.60
39 Depressed mood is not a risk factor for incident dementia in a community-based cohort. Am J Geriatr Psychiatry 2009 1.54
40 Mean template for tensor-based morphometry using deformation tensors. Med Image Comput Comput Assist Interv 2007 1.52
41 Abnormal regional cerebral blood flow in cognitively normal elderly subjects with hypertension. Stroke 2008 1.51
42 Patterns of mild cognitive impairment after treatment of depression in the elderly. Am J Geriatr Psychiatry 2009 1.48
43 APOE ε4 increases risk for dementia in pure synucleinopathies. JAMA Neurol 2013 1.41
44 Ventricular volume and dementia progression in the Cardiovascular Health Study. Neurobiol Aging 2006 1.36
45 Cerebral ventricular changes associated with transitions between normal cognitive function, mild cognitive impairment, and dementia. Alzheimer Dis Assoc Disord 2007 1.35
46 Event-related functional magnetic resonance imaging investigation of executive control in very old individuals with mild cognitive impairment. Biol Psychiatry 2005 1.28
47 The effect of midlife physical activity on cognitive function among older adults: AGES--Reykjavik Study. J Gerontol A Biol Sci Med Sci 2010 1.28
48 Commentary on "Developing a national strategy to prevent dementia: Leon Thal Symposium 2009." Dementia risk indices: A framework for identifying individuals with a high dementia risk. Alzheimers Dement 2010 1.27
49 Physical activity, brain plasticity, and Alzheimer's disease. Arch Med Res 2012 1.27
50 White matter lesions and brain gray matter volume in cognitively normal elders. Neurobiol Aging 2011 1.26
51 The effects of physical activity, education, and body mass index on the aging brain. Hum Brain Mapp 2010 1.26
52 Association of CLU and PICALM variants with Alzheimer's disease. Neurobiol Aging 2010 1.22
53 Neuropathologic correlates of late-onset major depression. Neuropsychopharmacology 2004 1.21
54 Multivariate statistics of the Jacobian matrices in tensor based morphometry and their application to HIV/AIDS. Med Image Comput Comput Assist Interv 2006 1.19
55 Pulse wave velocity is associated with β-amyloid deposition in the brains of very elderly adults. Neurology 2013 1.18
56 Multivariate tensor-based morphometry on surfaces: application to mapping ventricular abnormalities in HIV/AIDS. Neuroimage 2009 1.18
57 Classification of amyloid-positivity in controls: comparison of visual read and quantitative approaches. Neuroimage 2013 1.17
58 In vivo assessment of amyloid-β deposition in nondemented very elderly subjects. Ann Neurol 2013 1.17
59 Early AD pathology in a [C-11]PiB-negative case: a PiB-amyloid imaging, biochemical, and immunohistochemical study. Acta Neuropathol 2012 1.16
60 Cognitive trajectories associated with β-amyloid deposition in the oldest-old without dementia. Neurology 2013 1.11
61 Positron emission tomography imaging of peripheral benzodiazepine receptor binding in human immunodeficiency virus-infected subjects with and without cognitive impairment. J Neurovirol 2006 1.07
62 Trajectories of cognitive decline in Alzheimer's disease. Int Psychogeriatr 2009 1.06
63 TOMM40 poly-T repeat lengths, age of onset and psychosis risk in Alzheimer disease. Neurobiol Aging 2011 1.05
64 Identifying mild cognitive impairment at baseline in the Ginkgo Evaluation of Memory (GEM) study. Aging Ment Health 2009 1.02
65 Creating a transatlantic research enterprise for preventing Alzheimer's disease. Alzheimers Dement 2009 1.02
66 Plasma and cerebrospinal fluid alpha1-antichymotrypsin levels in Alzheimer's disease: correlation with cognitive impairment. Ann Neurol 2003 1.01
67 Psychosis in Alzheimer disease: postmortem magnetic resonance spectroscopy evidence of excess neuronal and membrane phospholipid pathology. Neurobiol Aging 2002 1.00
68 Trajectory of cognitive decline as a predictor of psychosis in early Alzheimer disease in the cardiovascular health study. Am J Geriatr Psychiatry 2011 1.00
69 Effect of Alzheimer's disease risk genes on trajectories of cognitive function in the Cardiovascular Health Study. Am J Psychiatry 2012 1.00
70 Effects of donepezil on activities of daily living: integrated analysis of patient data from studies in mild, moderate and severe Alzheimer's disease. Int Psychogeriatr 2010 1.00
71 Amyloid imaging in dementias with atypical presentation. Alzheimers Dement 2012 0.99
72 Prediction of psychosis onset in Alzheimer disease: The role of cognitive impairment, depressive symptoms, and further evidence for psychosis subtypes. Am J Geriatr Psychiatry 2006 0.98
73 Focal atrophy and cerebrovascular disease increase dementia risk among cognitively normal older adults. J Neuroimaging 2007 0.97
74 Functional connectivity measured with magnetoencephalography identifies persons with HIV disease. Brain Imaging Behav 2012 0.96
75 Effectiveness of donepezil in reducing clinical worsening in patients with mild-to-moderate alzheimer's disease. Dement Geriatr Cogn Disord 2009 0.96
76 Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans. Proc Natl Acad Sci U S A 2012 0.95
77 Markers of cholesterol metabolism in the brain show stronger associations with cerebrovascular disease than Alzheimer's disease. J Alzheimers Dis 2012 0.95
78 Psychosis in Alzheimer's disease in the national Alzheimer's disease coordinating center uniform data set: clinical correlates and association with apolipoprotein e. Int J Alzheimers Dis 2011 0.94
79 The relationship of excess cognitive impairment in MCI and early Alzheimer's disease to the subsequent emergence of psychosis. Int Psychogeriatr 2008 0.94
80 Concurrent validity of a computer-based cognitive screening tool for use in adults with HIV disease. AIDS Patient Care STDS 2011 0.94
81 Mapping cerebellar degeneration in HIV/AIDS. Neuroreport 2008 0.93
82 Basal forebrain atrophy is a presymptomatic marker for Alzheimer's disease. Alzheimers Dement 2008 0.92
83 Potential utility of resting-state magnetoencephalography as a biomarker of CNS abnormality in HIV disease. J Neurosci Methods 2012 0.92
84 β-Amyloid 42/40 ratio and kalirin expression in Alzheimer disease with psychosis. Neurobiol Aging 2012 0.91
85 Imaging cerebral blood flow in the cognitively normal aging brain with arterial spin labeling: implications for imaging of neurodegenerative disease. J Neuroimaging 2009 0.91
86 Does Ginkgo biloba reduce the risk of cardiovascular events? Circ Cardiovasc Qual Outcomes 2009 0.90
87 Hippocampal volume is related to body mass index in Alzheimer's disease. Neuroreport 2011 0.90
88 No association of psychosis in Alzheimer disease with neurodegenerative pathway genes. Neurobiol Aging 2010 0.90
89 Pulmonary function impairment may be an early risk factor for late-life cognitive impairment. J Am Geriatr Soc 2013 0.89
90 A pilot study of the effects of internet-based cognitive stimulation on neuropsychological function in HIV disease. Disabil Rehabil 2012 0.88
91 Common folate gene variant, MTHFR C677T, is associated with brain structure in two independent cohorts of people with mild cognitive impairment. Neuroimage Clin 2012 0.88
92 Prediction of psychosis onset in Alzheimer disease: the role of depression symptom severity and the HTR2A T102C polymorphism. Am J Med Genet B Neuropsychiatr Genet 2007 0.87
93 Long-term survival in adults 65 years and older with white matter hyperintensity: association with performance on the digit symbol substitution test. Psychosom Med 2013 0.87
94 Alterations in the hemodynamic response function in cognitively impaired HIV/AIDS subjects. J Neurosci Methods 2007 0.87
95 Localized measures of callosal atrophy are associated with late-life hypertension: AGES-Reykjavik Study. Neuroimage 2008 0.86
96 Validity, significance, strengths, limitations, and evidentiary value of real-world clinical data for combination therapy in Alzheimer's disease: comparison of efficacy and effectiveness studies. Neurodegener Dis 2012 0.85
97 Fractal analysis of retinal vessels: peeping at the tree of life? Neurology 2010 0.85
98 Rarity of the Alzheimer disease-protective APP A673T variant in the United States. JAMA Neurol 2015 0.84
99 Change in inflammatory markers and cognitive status in the oldest-old women from the Study of Osteoporotic Fractures. J Am Geriatr Soc 2014 0.83
100 Effect of Ginkgo biloba on blood pressure and incidence of hypertension in elderly men and women. Am J Hypertens 2010 0.83
101 Review of 'the potential role of arterial stiffness in the pathogenesis of Alzheimer's disease'. Neurodegener Dis Manag 2015 0.83
102 Measuring physical activity using accelerometry in a community sample with dementia. J Am Geriatr Soc 2013 0.83
103 The American Psychiatric Association Practice Guideline on the Use of Antipsychotics to Treat Agitation or Psychosis in Patients With Dementia. Am J Psychiatry 2016 0.83
104 Psychotic symptoms in Alzheimer disease: evidence for subtypes. Am J Geriatr Psychiatry 2003 0.83
105 Effectiveness of antidementia drugs in delaying Alzheimer's disease progression. Alzheimers Dement 2012 0.82
106 Dementia and Alzheimer's disease: a new direction.The 2010 Jay L. Foster Memorial Lecture. Alzheimers Dement 2011 0.82
107 Apolipoprotein E and alpha-1-antichymotrypsin genotypes do not predict time to psychosis in Alzheimer's disease. J Geriatr Psychiatry Neurol 2002 0.82
108 Longer lithium exposure is associated with better white matter integrity in older adults with bipolar disorder. Bipolar Disord 2014 0.81
109 Genetic association between APOE*4 and neuropsychiatric symptoms in patients with probable Alzheimer's disease is dependent on the psychosis phenotype. Behav Brain Funct 2012 0.81
110 Gene-environment interactions with cognition in late life and compression of morbidity. Am J Psychiatry 2007 0.81
111 Dementia: is it time for a change in focus? Alzheimers Dement 2007 0.81
112 Beta-amyloid toxicity modifier genes and the risk of Alzheimer's disease. Am J Neurodegener Dis 2012 0.81
113 Alzheimer disease with psychosis: excess cognitive impairment is restricted to the misidentification subtype. Am J Geriatr Psychiatry 2004 0.81
114 Effects of image normalization on the statistical analysis of perfusion MRI in elderly brains. J Magn Reson Imaging 2008 0.80
115 The expanding role of genetics in the lewy body diseases: the glucocerebrosidase gene. Arch Neurol 2009 0.79
116 Brain structural and functional recovery following initiation of combination antiretroviral therapy. J Neurovirol 2012 0.78
117 Collaborative research between academia and industry using a large clinical trial database: a case study in Alzheimer's disease. Trials 2011 0.78
118 Empirically Derived Trajectories to Dementia Over 15 Years of Follow-up Identified by Using Mixed Membership Models. Am J Epidemiol 2015 0.77
119 Commentary on "Developing a national strategy to prevent dementia: Leon Thal Symposium 2009." Is dementia among older individuals 75+ a unique disease? Alzheimers Dement 2010 0.77
120 Altered Levels of Visinin-Like Protein 1 Correspond to Regional Neuronal Loss in Alzheimer Disease and Frontotemporal Lobar Degeneration. J Neuropathol Exp Neurol 2016 0.76
121 Gray matter atrophy associated with extrapyramidal signs in the Lewy body variant of Alzheimer's disease. J Alzheimers Dis 2012 0.76
122 Response to Gary Esses and Stacie Deiner. J Am Geriatr Soc 2015 0.75
123 Response to Carnahan. Am J Psychiatry 2014 0.75
124 Commentary: "Treatment of hypertension and prevention of dementia" by Olivier Hanon and Françoise Forette. Alzheimers Dement 2005 0.75
125 Alzheimer disease subjects with psychosis have increased schizotypal symptoms before dementia onset. Biol Psychiatry 2005 0.75
126 Coronary Artery Bypass Graft Surgery and Dementia Risk in the Cardiovascular Health Study. Alzheimer Dis Assoc Disord 2017 0.75